Yazar "Ergenç, İlkay" için listeleme
-
Clinical and biochemical characteristics of a danish and turkish cohort of incident and prevalent patients with primary biliary cholangitis
Eruzun, Hasan; Bossen, Lars; Gökçe, Dilara Turan; Ergenç, İlkay; Harput, Zekiye Nur; Aydemir, Neslihan Güneş; Kayhan, Meral Akdoğan; Yapıcı, Hasan Basri; Doğan, Tugay; Holland-Fischer, Peter; Hansen, Jesper Bach; Yılmaz, Yusuf; Sezgin, Orhan; Adanır, Haydar; Bektaş, Ahmet; Grønbæk, Henning (AVES, 2025)Background/Aims: Primary biliary cholangitis (PBC) is a chronic liver disease influenced by environmental, genetic, and epigenetic factors, with varying incidence across populations. This study compared demographic, ... -
Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients
Ergenç, İlkay; Gözaydinoğlu, Büşra; Keklikkıran, Çağlayan; Yılmaz, Yusuf (Kare Publishing, 2024)We carefully considered the letter entitled “Optimal testing strategies for incidental anti-mitochondrial M2 antibody-positive patients.” We sincerely appreciate the authors’ insights and the thoughtful review of our ... -
Prevalence of metabolic dysfunction-associated steatotic liver disease and steatohepatitis in Türkiye: A forensic autopsy study
Ergenç, İlkay; Kara, Erdoğan; Yılmaz, Muhammed Emre; Demirtaş, Coşkun Özer; Keklikkıran, Çağlayan; Daş, Taner; Büyük, Yalçın; Çelikel, Çiğdem; Aslıyüksek, Hızır; Yılmaz, Yusuf (Elsevier, 2024)Background and aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global epidemic in T & uuml;rkiye and worldwide. The aim of this study was to evaluate the prevalence and predictors of ... -
The risk of development of primary biliary cholangitis among incidental antimitochondrial M2 antibody-positive patients
Ergenç, İlkay; Gözaydınoğlu, Büşra; Keklikkıran, Çağlayan; Yılmaz, Yusuf (Kare Publishing, 2023)Background and Aim: This study investigated the risk of the development of primary biliary cholangitis (PBC) in individuals who were incidentally identified as having positive antimitochondrial antibodies (AMA)-M2.Materials ...
